Integrative single‑cell and bulk transcriptomic profiling reveals MMP1 as a core effector and CTSB as a putative collaborator in ATBC‑aggravated pulmonary fibrosis.
Aug 2026· Gene· pp.
150347
· 0 citations· 29 references
Medicine
TL;DR
Intratracheal instillation exposure to ATBC may aggravate fibrosis progression on the basis of pre‑existing lung injury, with MMP1 serving as a core effector molecule, and preliminary experimental support for the safety assessment of plasticizers following respiratory tract exposure is offered.
Abstract
Background
Acetyl tributyl citrate (ATBC) is a widely used environmentally friendly plasticizer, and exposure via the respiratory tract is common in the general population. However, its pulmonary toxicity and underlying molecular mechanisms remain poorly understood.
Methods
An integrative strategy combining compound target prediction, IPF transcriptome screening, Bootstrap LASSO stability selection, and protein‑protein interaction network topological analysis was used to identify core targets. Single-cell transcriptomics was applied to dissect the cellular localization and functional roles of these targets. A bleomycin‑induced mouse pulmonary fibrosis model was employed to assess the effects of intratracheal instillation exposure to ATBC.
Results
Two core targets, MMP1(matrix metalloproteinase-1) and CTSB(cathepsin B), were identified from 17 candidate genes. Single-cell analysis revealed that MMP1 exhibits an "off-on" regulatory pattern in airway epithelial club cells-it is not expressed under steady‑state conditions but is specifically induced upon activation. In contrast, CTSB is highly expressed in macrophages and enhances pro‑fibrotic communication. The two targets exert complementary functions: MMP1⁺club cells enter a translationally hyperactive state involved in basement membrane remodeling, while CTSB⁺ macrophages amplify pro‑fibrotic signaling. Animal experiments showed that ATBC dose‑dependently exacerbates pulmonary fibrosis and upregulates MMP1 protein expression.
Conclusions
Intratracheal instillation exposure to ATBC may aggravate fibrosis progression on the basis of pre‑existing lung injury, with MMP1 serving as a core effector molecule. These findings offer preliminary experimental support for the safety assessment of plasticizers following respiratory tract exposure.
BACKGROUND
Current pharmacotherapies for chronic kidney disease (CKD) are limited by adverse effects and a "one-target-one-drug" paradigm. Necroptosis is a key driver of renal deterioration, yet its regulatory network remains poorly defined. Modified Da-Huang-Fu-Zi Decoction (DHFZ) has shown clinical efficacy, although...
Si-Teng Zhang, Wei Zhu, Guo-Fang Huang et al.· Computational biology and ch...· 0 citations
These findings identify CDC20 as a recurrence-associated molecular node involved in BaP-responsive malignant biological phenotypes and provide a phenotype-anchored framework linking recurrence biology with environmental exposure-related tumor behavior.
Xu-Chao Dai, Wei Gu, Bo Yu et al.· Frontiers in Cell and Develo...· 0 citations
TSPAN32 is nominated as the primary SCFA-responsive effector gene in intestinal epithelial cells, coordinating epigenetic remodeling and immunometabolic reprogramming and support TSPAN32 as a predicted network-stabilizing node rather than merely a differentially expressed transcript.
Zahra Masood, Iqra Sarwar, Ayesha Sanam et al.· Frontiers in Bioinformatics· 0 citations
A macrophage-centered anoikis-related immune signature in atherosclerosis is defined and HAVCR2 is identified, together with CD36, PLAU, TNF, PYCARD, SERPINA1, BLNK, and CHI3L1, as potential biomarkers and candidate targets for future diagnostic and therapeutic investigation.
Qiang Shen, Zheng-Feng Fan, Jin-Cheng Hou et al.· Frontiers in Immunology· 0 citations
The oncogenic ELFN1-AS1/LYPLA1 regulatory cascade is characterized as a potential biomarker and therapeutic target for precision management of osteosarcoma and establishes an LMRL-based for osteosarcoma prognostic stratification that reflects immune, genomic and therapeutic heterogeneity.
Xian-Fu Wei, Zhi-Peng Wang, Qiang Yang et al.· Frontiers in Immunology· 0 citations
This study prioritizes TPT1 as a candidate molecular marker associated with the bulk-transcriptomic sarcopenia phenotype and network and gene set variation analyses associated lower TPT1 expression with inflammatory, oxidative-stress, cell-death, and stress-adaptive pathways.
Shijie Dong, Min Wang, Chen Liang et al.· Frontiers in Cell and Develo...· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.